Background Low socioeconomic status is correlated with worse outcomes in patients with
cystic fibrosis (CF). Whether insurance status impacts adherence to care in this population is …

Background As the life expectancy of the cystic fibrosis (CF) population is lengthening with
modulator therapies, diligent age-appropriate screening and preventive care are …

Rationale: Health insurance coverage has been implicated as a socioeconomic factor
affecting clinical outcomes in patients with cystic fibrosis (CF), but evidence for this is mixed …

Health insurance coverage is associated with outcomes in cystic fibrosis (CF). A fraction of
individuals in the United States are covered through Tricare, a federally funded program for …

Summary Background The Patient Protection and Affordable Care Act (ACA), enacted in
2010, expanded private insurance coverage of young adults through the dependent …

Background Longer survival of patients with cystic fibrosis (CF) has been linked to initiation
of national newborn screening, new therapies that prevent and treat pulmonary …

With improved survival and new therapies for people with cystic fibrosis (CF), updated
information on medical care expenditures for those individuals is needed. We estimated …

Purpose To conduct an analysis describing clinical characteristics, pulmonary exacerbation
(PEx) events, and health care resource utilization among Medicaid-insured patients with …

Objectives Cystic fibrosis (CF) is a rare genetic multi-system disease; significant morbidity
occurs among patients with CF particularly due to pulmonary exacerbations (PEx). This …

BACKGROUND: Persons with cystic fibrosis (CF) who tend to be hospitalized have poorer
overall survival and quality of life. Whether differences exist in hospitalization rates between …